NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 141 filers reported holding NOVAVAX INC in Q1 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,082,000 | -44.3% | 209,697 | -9.4% | 0.16% | -39.1% |
| Q4 2015 | $1,941,000 | +20.6% | 231,352 | +1.6% | 0.26% | +15.5% |
| Q3 2015 | $1,609,000 | -48.8% | 227,631 | -19.3% | 0.23% | -41.8% |
| Q2 2015 | $3,144,000 | -47.6% | 282,208 | -61.1% | 0.39% | -44.8% |
| Q1 2015 | $5,997,000 | +11.3% | 725,166 | -20.2% | 0.70% | -0.8% |
| Q4 2014 | $5,388,000 | +72.1% | 908,534 | +21.0% | 0.71% | +52.5% |
| Q3 2014 | $3,131,000 | -10.0% | 750,926 | -0.2% | 0.46% | -10.7% |
| Q2 2014 | $3,477,000 | +266.8% | 752,513 | +259.7% | 0.52% | +184.7% |
| Q1 2014 | $948,000 | +135.2% | 209,230 | +165.9% | 0.18% | +137.7% |
| Q4 2013 | $403,000 | +89.2% | 78,677 | +16.6% | 0.08% | +63.8% |
| Q3 2013 | $213,000 | +86.8% | 67,503 | +21.8% | 0.05% | +74.1% |
| Q2 2013 | $114,000 | – | 55,403 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |